Track the 乐普医疗 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 乐普医疗 has published 1 insider filings. Market capitalisation: €24.1bn. The latest transaction was filed on 23 March 2022 (Sale). Among the most active insiders: 郭女士. Every trade is accessible without an account.
Analysts rate 乐普医疗 Strong Buy (bullish), based on 4 analysts. Average price target: CN¥19.39.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
乐普医疗 is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for medical diagnosis and treatment. It is listed on the XSHE market.